Dare Bioscience, Inc. Proceeds from Sale of Productive Assets
Dare Bioscience, Inc. (DARE) reported Proceeds from Sale of Productive Assets of $1.89 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2017-08-14
- Dare Bioscience, Inc. proceeds from sale of productive assets for the quarter ending 2017-06-30 was $394.00K.
- Dare Bioscience, Inc. proceeds from sale of productive assets for the quarter ending 2017-03-31 was $1.50M.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month |
|---|---|---|
| 2017-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.89M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.50M 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |